Nadia Warner

机构：The Royal Melbourne Hospital, Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute · ORCID：0000-0002-4252-086X

发表论文 66 篇 · 总被引 1570 次 · h-index 15

代表论文

• Targeted protein degraders of SARS-CoV-2 Mpro are more active than enzymatic inhibition alone with activity against nirmatrelvir resistant virus (2025 · Communications Medicine · 被引 15)
• Kinetics and Predictors of Hepatitis B Surface Antigen Loss After Commencing Hepatitis B Virus (HBV)–Active Antiretroviral Therapy in the Setting of HIV and Chronic HBV Coinfection (2025 · Clinical Infectious Diseases · 被引 6)
• Targeted protein degraders of SARS-CoV-2 Mpro demonstrate superior antiviral activity over enzymatic inhibition alone and potency against nirmatrelvir resistant virus (2024 · Research Square · 被引 3)
• Anti-HBs Immune Complex Levels: A Novel Marker of Hepatitis Flare Following Nucleos(t)ide Analog Withdrawal in HBeAg-negative Chronic Hepatitis B (2025 · The Journal of Infectious Diseases · 被引 1)
• Human Liver Organoids as a Patient-derived Model for HBV Infection and Cellular Response (2022 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)
• Author response for "VHL-independent degradation of Hepatitis B Virus e antigen (HBeAg) by VHL-binding chimeric small molecules" (2025)